Systemic effects of NAFLD, including gastrointestinal and cardiovascular diseases, diabetes and cancer, will be discussed as well as diagnostic methods and therapeutical approaches.
This conference is intended to bring together European experts, both basic scientists and clinicians, working in the field of the liver and associated diseases.
Our aim is to create sufficient opportunities to interact with colleagues for scientific discussions in an unofficial atmosphere and to start new (international) collaborations.
The 2015 event was accredited by EACCME and assigned 10 European CME Credits (ECMEC). Accrediation for the 2018 event has been requested for.